Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1981
10/06/1981US4293654 Crosslinging dextran beads
10/06/1981US4293491 Derivatives of A-30912H nucleus
10/06/1981US4293490 A-30912H Nuclei
10/06/1981US4293489 Antifungal peptides
10/06/1981US4293488 Derivatives of A-30912B nucleus
10/06/1981US4293487 Derivatives of A-30912D nucleus
10/06/1981US4293486 Antifungal peptides
10/06/1981US4293485 Peptide fungicide
10/06/1981US4293484 Derivatives of A-30912H nucleus
10/06/1981US4293483 Derivatives of A-30912A nucleus
10/06/1981US4293482 Peptide antibiotics
10/06/1981US4293481 Tripeptide inhibitors of angiotensin-converting enzyme
10/06/1981US4293455 Solid phase synthesis; immunology; potentiation of lymphatic leukocytes; anticarcinogenic agents; hormones
10/06/1981CA1110232A1 Peptide which inhibits gonadal function
10/06/1981CA1110187A1 Protein immobilizer
10/01/1981WO1981002737A1 Mucopolysaccharides having biological properties,preparation and application thereof as drugs
09/1981
09/30/1981EP0036776A2 A method of creating an expression plasmid
09/30/1981EP0036713A2 Angiotensin converting enzyme inhibitors
09/30/1981EP0036514A2 Use of a substance obtained from blood serum for the stabilization of prostaglandins
09/30/1981EP0036420A1 Peptides having imunostimulating properties and pharmaceutical compositions containing them.
09/30/1981EP0036415A1 Process for preparing a collagen product for medical and cosmetic use.
09/29/1981USRE30753 Containing amino acids, liver extract, insulin, antibiotic, fungicide
09/29/1981US4292313 Luteinizing hormone releasing hormone; antifertility agents
09/29/1981CA1109796A1 Process for the production of novel antidiarrheal agents
09/22/1981US4291022 Organic compounds
09/22/1981US4291013 Medicinally useful, shaped mass of collagen resorbable in the body
09/22/1981US4290943 Method of preparing polypeptides
09/22/1981CA1109394A1 Method of contraception
09/17/1981WO1981002522A1 Tumor localization and therapy with labeled antibodies and antibody fragments specific to tumor-associated markers
09/17/1981WO1981002520A1 Compositions for therapeutic or diagnostic use in connection with bacterial infections,and their use
09/16/1981EP0035856A2 Pharmaceutical and dietary compositions
09/15/1981US4289851 Process for producing cyclosporin derivatives
09/15/1981US4289850 Cultures, cells, polynucleotides
09/15/1981US4289759 Restoring immune system to normal state
09/15/1981US4289692 Derivatives of A-30912D nucleus
09/15/1981US4289691 From blood plasma by cryogenic precipitation
09/15/1981US4289689 Preparation of homogeneous human fibroblast interferon
09/15/1981US4289688 Protein-bound polysaccharides
09/15/1981CA1109060A1 Peptide derivatives and pharmaceutical compositions containing same
09/09/1981EP0035484A2 Composition for therapeutic or diagnostic use
09/09/1981EP0035454A2 Desacetylthymosin alpha 1, its process of preparation and its use
09/09/1981EP0035383A1 Angiotensin converting enzyme inhibitors
09/09/1981EP0035265A2 Agent for tumor localization and therapy with labeled antibodies and antibody fragments
09/09/1981EP0035204A2 Pasteurized therapeutically active protein compositions
09/09/1981EP0035202A2 Method of blood plasma fractionation
09/09/1981EP0035102A1 Oligopeptide selectively inhibiting the growth or multiplication of normal and leukaemic myeloid cells, to be isolated from healthy white blood cells or granulocytes, process for its preparation, and medicaments containing it
09/09/1981EP0035038A1 Peripheral circulation failure-curing agent
09/09/1981EP0035026A1 A process for preparing an injectable insulin preparation
09/08/1981US4288549 Method of producing the A-30912 antibiotics
09/08/1981US4288542 Methylation with transferase
09/08/1981US4288433 Thioether and a xanthine derivative
09/08/1981US4288432 Novel enkephalin analogs and process for the preparation thereof
09/08/1981US4288431 Culturing tolyplocladium, catalytic hydrogenation, rearrangement; antiinflammatory, immunology
09/08/1981CA1108535A1 Protein and process for isolating it
09/08/1981CA1108534A1 LEUCINE-RICH 3,1-S-.alpha..SUB.2-GLYCOPROTEIN, PROCESS FOR ISOLATING IT AND ITS USE
09/03/1981WO1981002425A1 The use of eucaryotic promoter sequences in the production of proteinaceous materials
09/02/1981EP0034795A2 Process for the preparation of photoresist layers for micro-electroforming by X-rays
09/02/1981EP0034721A2 Polypeptide and its production and use
09/01/1981USRE30731 Enkephalin analogues
09/01/1981US4287185 Method for the detection of viruses
09/01/1981US4287184 Process for healing wounds
09/01/1981US4287180 Method for treating blood clotting factor inhibitors
09/01/1981US4287120 Useful as fungicides
09/01/1981CA1108125A1 Olgiopeptide derivatives of phosphonic acid
09/01/1981CA1108124A1 ANTAGONISTIC ANGIOTENSION II ANALOGUES CONTAINING AN .alpha.-AMINOOXYACID IN THE POSITION-1
09/01/1981CA1108123A1 Psychopharmacological peptides suitable for therapeutic administration
09/01/1981CA1108050A1 Storagestable cholesterol oxidase composition
08/1981
08/26/1981EP0034567A2 A method for the total synthesis of cyclosporins and novel cyclosporins
08/26/1981EP0034260A1 Peptides, process for their preparation and medicaments or diagnostic agents containing them
08/26/1981EP0034259A1 Peptides, process for their preparation and medicaments or diagnostic agents containing them
08/25/1981US4286064 Basification
08/25/1981US4286063 Method for producing thrombolytic preparation
08/25/1981US4286056 Activating prothrombin complex
08/25/1981US4285935 Antitumor agents, histolytic medicaments
08/25/1981US4285933 Process for concentrating blood coagulation Factor XIII derived from human placentae
08/25/1981US4285932 Enzyme derivatives for use in the treatment of venous thrombosis
08/25/1981US4285929 Induction
08/25/1981US4285858 Vasopressin analogs
08/25/1981US4285857 Cyclic analogues of callidine
08/25/1981CA1107722A1 2-(2-acetamido2-deoxy-3-o-d-glucopyranosy)-d- propionyl-l-seryl-d-isoglutamine, 2-(2-acetamido-2- deoxy-3-o-d-glucopyranosyl)-d-propionyl-l-seryl-d- glutamic acid, ester and amidederivatives thereof, and medicaments containing them
08/25/1981CA1107649A1 Method of separating a factor ix preparation from plasma
08/25/1981CA1107648A1 Glycoprotein and process for isolating it
08/25/1981CA1107647A1 Stable secretin composition, process for its preparation and its use
08/25/1981CA1107646A1 Anti-microbial composition
08/19/1981EP0034083A1 Process for the treatment of a material based on casein containing phosphocaseinates of monovalent cations or their derivatives, products obtained and applications
08/19/1981EP0034034A1 Nutrient composition
08/18/1981US4284780 Amino acid derivatives
08/18/1981US4284779 Angiotensin enzyme inhibitors, hypotensive agents
08/18/1981US4284624 Mixed disulfides
08/18/1981US4284587 Methylation with transferase, purification
08/18/1981US4284537 Polylysine
08/18/1981CA1107273A1 Somatostatin analogs having a substituted tryptophyl residue in position eight
08/18/1981CA1107208A1 Stabilized biochemical preparations, preparation and use thereof
08/12/1981EP0033694A2 Process for producing stabilized hydrolysates of animal proteins, products obtained and dietetic and therapeutic application
08/12/1981EP0033686A2 Process for treating a raw material based on casein containing phosphocaseinates of divalent cations, products obtained and applications
08/12/1981EP0033582A2 Method of obtaining factor VIII
08/12/1981EP0033579A2 Hybrid cell line for producing monoclonal antibody to a human monocyte antigen, antibody, and methods
08/12/1981EP0033578A2 Hybrid cell line for producing monoclonal antibody to a human T cell antigen, antibody, and methods
08/12/1981EP0033504A2 Pentapeptides of the encephaline type, process for their preparation and medicaments containing these
08/12/1981EP0033384A2 Medicaments containing fragments of thymosin-alpha-1 with immunostimulating activity, and thymosin-alpha-1 fragments